The most common dermatological manifestations of inflammatory bowel diseases
DOI:
https://doi.org/10.12775/JEHS.2023.29.01.002Keywords
inflammatory bowel disease, dermatological manifestations, extraintestinal manifestations, skinAbstract
Inflammatory bowel diseases are increasingly common problem in clinical practice. This condition is caused by both the growing morbidity and more accurate and widely available diagnostic methods, affecting the rising recognition.
It is worth remembering, that clinical presentation of inflammatory bowel disease is not limited to gastrointestinal tract.
Dermatological symptoms are an important part in the diagnosis of inflammatory bowel diseases, because they can occur as the first manifestation of the beginning of the disease process, as well as be a prognostic factor for the occurrence of exacerbations of the disease. This is an invaluable source of information on the patient's clinical condition, affecting the effectiveness of his treatment in the early stages of the disease, and allowing more efficient control of its course.
This has an enormous impact on the prognosis and comfort of patients' lives. In the following article, available medical studies on extraintestinal skin manifestations, clinical presentation and treatment options have been reviewed.
References
Satsangi J., Grootscholten C., Holt H., Jewell DP. Clinical patterns of familial inflammatory bowel disease. Gut 1996; 38: 738-774.
Wojtuń S, Gil J., Szwed Ł., Dyrla P. Basic symptoms and differentiation of inflammatory bowel diseases; March 2014, Pediatria i Medycyna Rodzinna 10(1):61-66; DOI:10.15557PiMR.2014.0009
Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management. Gastroenterology. 2021 Oct;161(4):1118-1132. doi: 10.1053/j.gastro.2021.07.042. Epub 2021 Aug 3. PMID: 34358489; PMCID: PMC8564770.
Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001 Apr;96(4):1116-22. doi: 10.1111/j.1572-0241.2001.03756.x. PMID: 11316157.
Munkholm P, Binder V. Clinical features and natural history of Crohn’s disease. In: Sartor R, Sandborn W, editors. Kirsner’s inflammatory bowel diseases. 6th edition. Philadelphia: Saunders; 2004. p. 289-300.
Thoreson R, Cullen JJ. Pathophysiology of inflammatory bowel disease: an overview. Surg Clin North Am. 2007 Jun;87(3):575-85. doi: 10.1016/j.suc.2007.03.001. PMID: 17560413.
Greuter T, Navarini A, Vavricka SR. Skin Manifestations of Inflammatory Bowel Disease. Clin Rev Allergy Immunol. 2017 Dec;53(3):413-427. doi: 10.1007/s12016-017-8617-4. PMID: 28643285.
Plumptre I, Knabel D, Tomecki K. Pyoderma Gangrenosum: A Review for the Gastroenterologist. Inflamm Bowel Dis. 2018 Nov 29;24(12):2510-2517. doi: 10.1093/ibd/izy174. PMID: 29788368.
Jackson J.M., Callen J.P.: Pyoderma gangrenosum. eMedicine from We- bMD, (on-line), 2006.
Wollina U. Pyoderma gangrenosum--a review. Orphanet J Rare Dis. 2007 Apr 15;2:19. doi: 10.1186/1750-1172-2-19. PMID: 17433111; PMCID: PMC1857704.
Farhi D, Cosnes J, Zizi N, Chosidow O, Seksik P, Beaugerie L, Aractingi S, Khosrotehrani K. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore). 2008 Sep;87(5):281-293. doi: 10.1097/MD.0b013e318187cc9c. PMID: 18794711.
Vavricka SR, Rogler G, Gantenbein C, Spoerri M, Prinz Vavricka M, Navarini AA, French LE, Safroneeva E, Fournier N, Straumann A, Froehlich F, Fried M, Michetti P, Seibold F, Lakatos PL, Peyrin-Biroulet L, Schoepfer AM. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort. Inflamm Bowel Dis. 2015 Aug;21(8):1794-800. doi: 10.1097/MIB.0000000000000429. PMID: 26020601.
Blitz NM, Rudikoff D. Pyoderma gangrenosum. Mt Sinai J Med. 2001 Sep-Oct;68(4-5):287-97. PMID: 11514916.
Braun-Falco O., Plewig G., Wolff H.H., Burgdorf W.H.C.: Dermatologia. Czelej, Lublin 2002.
Garcovich S, De Simone C, Berti E, Marzano AV. Drug management of neutrophilic dermatoses. Expert Rev Clin Pharmacol. 2017 Oct;10(10):1119-1128. doi: 10.1080/17512433.2017.1356719. Epub 2017 Jul 27. PMID: 28715916.
Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol. 2005 Aug;53(2):273-83. doi: 10.1016/j.jaad.2004.10.006. PMID: 16021123.
Harbord M, Annese V, Vavricka SR, Allez M, Barreiro-de Acosta M, Boberg KM, Burisch J, De Vos M, De Vries AM, Dick AD, Juillerat P, Karlsen TH, Koutroubakis I, Lakatos PL, Orchard T, Papay P, Raine T, Reinshagen M, Thaci D, Tilg H, Carbonnel F; European Crohn’s and Colitis Organisation. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. J Crohns Colitis. 2016 Mar;10(3):239-54. doi: 10.1093/ecco-jcc/jjv213. Epub 2015 Nov 27. PMID: 26614685; PMCID: PMC4957476.
Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015 Aug;21(8):1982-92. doi: 10.1097/MIB.0000000000000392. PMID: 26154136; PMCID: PMC4511685.
von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol. 1994 Oct;31(4):535-56; quiz 557-60. doi: 10.1016/s0190-9622(94)70215-2. PMID: 8089280.
Dorofeyev AE, Vasilenko IV, Rassokhina OA. Joint extraintestinal manifestations in ulcerative colitis. Dig Dis. 2009;27(4):502-10. doi: 10.1159/000233289. Epub 2009 Nov 4. PMID: 19897966.
BARLING B. Idiopathic ulcerative colitis with severe ulceration of the skin and peritonitis. Proc R Soc Med. 1949 Feb;42(2):105. PMID: 18125061; PMCID: PMC2081039.
Turkcapar N, Toruner M, Soykan I, Aydintug OT, Cetinkaya H, Duzgun N, Ozden A, Duman M. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int. 2006 May;26(7):663-8. doi: 10.1007/s00296-005-0044-9. Epub 2005 Sep 1. PMID: 16136311.
Agrawal D, Rukkannagari S, Kethu S. Pathogenesis and clinical approach to extraintestinal manifestations of inflammatory bowel disease. Minerva Gastroenterol Dietol. 2007 Sep;53(3):233-48. PMID: 17912186.
Evans PE, Pardi DS. Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations. MedGenMed. 2007 Mar 19;9(1):55. PMID: 17435655; PMCID: PMC1925026.
Grygiel-Górniak B, Puszczewicz M: Diagnostyka róznicowa rumienia guzowatego. Med Dypl 2016; 25 (5): 48-54.
Blake T, Manahan M, Rodins K. Erythema nodosum - a review of an uncommon panniculitis. Dermatol Online J. 2014 Apr 16;20(4):22376. PMID: 24746312.
Timani S, Mutasim DF. Skin manifestations of inflammatory bowel disease. Clin Dermatol. 2008 May-Jun;26(3):265-73. doi: 10.1016/j.clindermatol.2007.10.018. PMID: 18640523.
Villarreal-Villarreal CD, Ocampo-Candiani J, Villarreal-Martínez A. Sweet Syndrome: A Review and Update. Actas Dermosifiliogr. 2016 Jun;107(5):369-78. English, Spanish. doi: 10.1016/j.ad.2015.12.001. Epub 2016 Jan 27. PMID: 26826881.
Marzano AV, Borghi A, Stadnicki A, Crosti C, Cugno M. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis. 2014 Jan;20(1):213-27. doi: 10.1097/01.MIB.0000436959.62286.f9. PMID: 24105394.
Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet's syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol. 2013 Oct;45(2):202-10. doi: 10.1007/s12016-012-8351-x. PMID: 23334898.
Wallach D, Vignon-Pennamen MD. Pyoderma gangrenosum and Sweet syndrome: the prototypic neutrophilic dermatoses. Br J Dermatol. 2018 Mar;178(3):595-602. doi: 10.1111/bjd.13955. Epub 2015 Jul 22. PMID: 26202386.
Hagen JW, Swoger JM, Grandinetti LM. Cutaneous Manifestations of Crohn Disease. Dermatol Clin. 2015 Jul;33(3):417-31. doi: 10.1016/j.det.2015.03.007. PMID: 26143422.
Lima CDS, Pinto RDB, Góes HFO, Salles SAN, Vilar EAG, Lima CDS. Sweet's syndrome associated with Crohn's disease. An Bras Dermatol. 2017 Mar-Apr;92(2):263-265. doi: 10.1590/abd1806-4841.20175298. PMID: 28538894; PMCID: PMC5429120.
Shahid Z, Kalayanamitra R, Patel R, Groff A, Jain R. Refractory Sweet Syndrome Treated with Anakinra. Cureus. 2019 Apr 24;11(4):e4536. doi: 10.7759/cureus.4536. PMID: 31263644; PMCID: PMC6592472.
Lankarani KB, Sivandzadeh GR, Hassanpour S. Oral manifestation in inflammatory bowel disease: a review. World J Gastroenterol. 2013 Dec 14;19(46):8571-9. doi: 10.3748/wjg.v19.i46.8571. PMID: 24379574; PMCID: PMC3870502.
Vatn MH, Sandvik AK. Inflammatory bowel disease. Scand J Gastroenterol. 2015 Jun;50(6):748-62. doi: 10.3109/00365521.2015.1033000. Epub 2015 Apr 8. PMID: 25855003.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Izabela Hop, Kacper Kołodziejczyk, Justyna Branewska, Barbara Ostrowska, Anna Olszanicka, Rafał Niemiec, Adam Galas, Mikołaj Matysek, Anna Maciąg, Jan Imioło
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 342
Number of citations: 0